Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TAK-676 |
Trade Name | |
Synonyms | TAK 676|TAK676 |
Drug Descriptions |
TAK-676 is a STING agonist, which results in activation of the STING pathway in immune cells, thereby potentially leading to activation of anti-tumor immune responses (NCI Drug Dictionary). |
DrugClasses | STING1 Agonist 19 |
CAS Registry Number | NA |
NCIT ID | C173377 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TAK-676 | Pembrolizumab TAK-676 | 0 | 2 |
TAK-676 | TAK-676 | 0 | 1 |